eDocTalk article

Legacy Health and The Oregon Clinic partner to create the Portland Parkinson's Program

April 2013

Legacy Health’s partnership with The Oregon Clinic to create the Portland Parkinson’s Program is an example of the range of structural models Legacy is pursuing with independent physicians.

 

Legacy Health and The Oregon Clinic are collaborating in a new way to offer multidisciplinary care for patients with Parkinson’s disease: the Portland Parkinson’s Program.

Between the providers in The Oregon Clinic and Legacy facilities, the Portland Parkinson’s Program will offer the full range of services needed to diagnose and treat this degenerative condition.

Adds The Oregon Clinic’s Richard Rosenbaum, M.D., "The Portland Parkinson’s Program is working with Legacy Rehab to develop a multidisciplinary clinic to assess patients’ rehabilitation needs and to direct the patients to our therapists who have special training and expertise in Parkinson’s Disease."

One of the goals of the new partnership is to facilitate communication and flow among the various providers who care for these patients, including primary care physicians, neurologists and rehabilitation specialists. Dr. Rosenbaum says, "We welcome contact from primary care providers. We are working with Legacy to improve communication about and continuing medical education on Parkinson’s Disease." Dr. Rosenbaum and his colleague, Brooke Walter, M.D., are at 503-935-8000.

Related Legacy Research Institute initiative

Legacy Health has recognized the opportunity to create a regional resource for neuroscience-related diseases. Stroke and Parkinson's disease are just two examples where Legacy and Legacy Research Institute (LRI) are working synergistically to transform care.

Through The Office of Philanthropy, Legacy has been working with potential major donors to create the Legacy Research Institute Initiative to Cure Parkinson's Disease. LRI has received initial matching funding from both the NW Parkinson’s Group and The Office of Philanthropy to support the preliminary studies that underpin the key principles associated with the larger project.

To date, most efforts to treat Parkinson’s disease have focused on alleviating symptoms with medications. Current research includes attempts at replacing or reconstructing the degenerating neurons of the brain that directly lead to Parkinsonian symptoms. LRI plans to develop innovative therapies to reconstruct adenosine, which is the brain’s own neuroprotectant molecule and is involved in the control of motor functions in the brain of PD patients.

Back to current edition home page